Delta Air Lines has announced that unvaccinated workers will be fined a $200 monthly health insurance surcharge and could lose pay protection for missing work if they get sick from the virus.
The Wall Street Journal reports that Delta’s approach focuses on the financial burden of Covid-19 and attempts to transfer it to those who aren’t vaccinated. Before now, employers have opted for incentives, such as cash bonuses, to motivated workers to get the Covid-19 vaccine. Others have chosen to mandate the vaccine for their business.
Delta Chief Executive Ed Bastian wrote to employees on Wednesday that the $200 monthly charge for unvaccinated workers that are enrolled in the company’s healthcare plan “will be necessary to address the financial risk the decision to not vaccinate is creating for our company.”
He also reported that 75% of the airline’s workers were already vaccinated (Bloomberg). Unvaccinated employees have a deadline of November 1st before the fee will be applied. Weekly testing will also be required for unvaccinated employees that do not receive a vaccine by mid-September.
Other airlines are taking precautions against the virus (CNBC). Alaska Airlines told employees it was considering requiring employees to be vaccinated. Frontier Airlines is requiring employees to either get vaccinated or be tested regularly.
United Airlines and Hawaiian Airlines have already mandated the vaccine, while Southwest Airlines, JetBlue Airways, and American Airlines are simply encouraging vaccination. The Air Line Pilots Association has maintained the stance that it is “the right of each individual pilot to consult with his or her medical provider regarding Covid-19 vaccinations or booster doses.”
ARTICLE: JILLIAN WEIDNER
MANAGING EDITOR: CARSON CHOATE
PHOTO CREDITS: FT.COM
Latest posts by Jillian Weidner (see all)
- Border patrol sets all-time record for arrests at southern border amid migrant surge - October 24, 2021
- FDA to allow Americans to ‘mix and match’ COVID-19 vaccine and booster shots - October 22, 2021
- Johns Hopkins Medicine receives federal grant for psychedelic treatment research, the first in over fifty years - October 21, 2021